The epigenomic interface between genome and environment in common complex diseases.
The epigenome plays the pivotal role as interface between genome and environment. True genome-wide assessments of epigenetic marks, such as DNA methylation (methylomes) or chromatin modifications (chromatinomes), are now possible, either through high-throughput arrays or increasingly by second-generation DNA sequencing methods. The ability to collect these data at this level of resolution enables us to begin to be able to propose detailed questions, and interrogate this information, with regards to changes that occur due to development, lineage and tissue-specificity, and significantly those caused by environmental influence, such as ageing, stress, diet, hormones or toxins. Common complex traits are under variable levels of genetic influence and additionally epigenetic effect. The detection of pathological epigenetic alterations will reveal additional insights into their aetiology and how possible environmental modulation of this mechanism may occur. Due to the reversibility of these marks, the potential for sequence-specific targeted therapeutics exists. This review surveys recent epigenomic advances and their current and prospective application to the study of common diseases.
University College London Cancer Institute, UK. christopher.bell@ucl.ac.uk
Christopher G
CG
Bell
Stephan
S
Beck
D000818:Animals; D005075:Biological Evolution; D019175:DNA Methylation; D004032:Diet; D004194:Disease / Q000235:genetics; D004777:Environment; D057890:Epigenomics; D016678:Genome; D006801:Humans; D009369:Neoplasms / Q000235:genetics; D012984:Software